zoledronate

Research Reports

Bone-Modifying Agent Utilization: An Analysis in Patients With Metastatic Cancer and Bone Involvement at an NCI-Designated Cancer Center

04/12/2023

Julie Gralow , MD, FACP, FASCO;

Micah Tratt ;

Keith D. Eaton , MD, PhD;

Poorni M. Manohar , MD;

Kyle E. Bastys ;

Manohar et al investigate the cost of utilizing bone-modifying agents in the treatment of patients with metastatic cancer and bone involvement at a National Cancer Institute–designated cancer center.

Manohar et al investigate the...

04/12/2023

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

See Full Calendar

zoledronate

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products